Nanocarrier-Based Targeted Therapies for Myocardial Infarction

MLA

Thomashire A. George, et al. “Nanocarrier-Based Targeted Therapies for Myocardial Infarction.” Pharmaceutics, vol. 14, no. 5, Apr. 2022, p. 930. EBSCOhost, https://doi.org/10.3390/pharmaceutics14050930.

APA

Thomashire A. George, Chuan-Chih Hsu, Annette Meeson, & David J. Lundy. (2022). Nanocarrier-Based Targeted Therapies for Myocardial Infarction. Pharmaceutics, 14(5), 930. https://doi.org/10.3390/pharmaceutics14050930

Chicago

Thomashire A. George, Chuan-Chih Hsu, Annette Meeson, and David J. Lundy. 2022. “Nanocarrier-Based Targeted Therapies for Myocardial Infarction.” Pharmaceutics 14 (5): 930. doi:10.3390/pharmaceutics14050930.